Drug Discovery Market To See Stunning Growth by 2027

1. Market Research Report EXCLUSIVE EDITION Global Drug Discovery Market Research Report Global Industry Analysis, Forecast and Trends, 2021-2027 © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

2. Global Drug Discovery Market Report Global Drug Discovery Market Report © 2020 Statsville Consulting Private Limited Market Statsville Group (MSG) A part of Statsville Consulting Private Limited American Office American Office – 416, East Standsberry Street, Perkins, Oklahoma 74059, USA EMEA EMEA– 1165 Budapest 16 Diósy Lajos u. 24., Europe Asia Asia- -Pacific Office Pacific Office – F-178 Subhash Marg C Scheme, Ashok Nagar, Jaipur, Rajasthan, 302001 www.marketstatsville.com Disclaimer Disclaimer: : Any information and/or material provided by Statsville Consulting Private Limited, including any and all the analysis and/or research from Market Statsville Group (MSG), is offered to a selected group of customers in response to orders for such information, material, analysis, and/or research. As a customer of Statsville Consulting, you acknowledge that our information, material, and/or services are for your internal use only, and not for any external use and/or dissemination, or general publication, and/or disclosure to any third parties. Any and all the information and/or material provided by Statsville Consulting are based on primary interviews and/or secondary research, and are, therefore, subject to fluctuation and variance. Statsville Consulting takes no responsibility for any incorrect information and/or material supplied to us by sources we rely on, and no part of our analysis or research may be given, lent, resold, or disclosed to any third parties, including non-customers, without explicit or written permission from Statsville Consulting. Unauthorized reproduction and/or transmission of our information, material, analysis, and/or research in any form and by any means, including photocopying, mechanical/electronic recording,or otherwise, without the explicit and written permission of Statsville Consulting, is expressly and clearly prohibited. Any use of the information, material, analysis, and/or research provided by Statsville Consulting is at your sole risk; you acknowledge that the information, material, analysis, and/or research is provided “as is” and that Statsville Consulting provides no warranty of any kind, express or implied, with regard to the information, material, analysis, and/or research, including but not limited to, merchantability and fitness for any purpose and/or use. At the end, Statsville Consulting will be responsiblefor the final decision of any action. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

3. ABOUT MARKET STATSVILLE GROUP (MSG) Market Statsville Group (MSG) partners with companies and society to confront their essential risks and challenges to capture the enormous opportunities for them. MSG was initiated its working in 2017, and since then, the brand is moving to become a pioneer in business advisory and market research services. Market Statsville is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in the form of market sizing, analysis, and incisive business insights. MSG experienced research analysts are proficient at digging deep and providing a variety of customizable data that help you make decisions with clarity, confidence, and impact. Market Statsville is your global data intelligence partner for reliable market research data, data gathering, and analytical services. MSG also has an extensive network of top-flight domestic and global research personals around the world, enabling us to provide high-quality worldwide research solutions that cater to a well-established company, government organizations, or a startup. MSG's clients have the authority to work directly with one or more of our researchers to gather the most useful data knowledge and analytical plan to formulate it in the actual practice. Market Statsville Group believes that to succeed, companies or individuals must blend digital and human capabilities most efficiently. MSG diverse and experienced global team of business consultants and market researchers will ensure the valuable reports for our clients through digging in-depth market information and functional expertise to continuously spark the changes and real-time valuation of variation in the market/industry. MSG works in a uniquely collaborative model throughout the business process across the globe to assist the client's company with the most accurate information that they are aiming for in the reports. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

4. RESEARCH PROCESS Our research is an optimum culmination of secondary and primary research, with the latter playing a major role. We also have an in-house repository and access to a number of external regional and global paid databases to help address specific requirements of our clients. The research process begins with a holistic secondary research, followed by expert interviews. The information gathered is then comprehensively analyzed by our highly experienced in-house research panel © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

5. Drug Discovery Market by Drug Type (Biologic Drugs, Small Molecule Drugs), by Technology (High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology), by End User, and Region - Global Trends, Market Share, and Forecast to 2027 Description Description The global drug discovery market global drug discovery market size was valued at USD 54,894.1 million in 2020 and is expected to reach USD 92,374.2 million by 2027, registering a CAGR of 8.49% during 2021-2027. Drug discovery process targets identifying a compound therapeutically useful in curing and treating diseases. Recently, drug discovery has evolved significantly with emerging technologies, helping the process become more refined, accurate, and less time-consuming. The growing prevalence of chronic diseases and the rising healthcare expenditure, and the upcoming patent expiration of blockbuster drugs are the major factors driving the drug discovery market's growth over the coming years. Also, as per the National Health Interview Survey (NHIS), 2018 data, nearly 51.8% of the American adults had at least one of ten selected diagnosed chronic diseases, which included arthritis, cancer, chronic obstructive pulmonary disease, coronary heart disease, asthma, diabetes, hepatitis, hypertension, stroke, and kidney disorders. Also, 27.2% of adults had multiple chronic conditions in the United States in 2018. Thus, the rising chronic diseases incidence is expected to surge the novel therapeutics demand, which is predicted to boost the drug discovery market growth during the forecast period. However, the huge capital investment with low-profit margins and stringent government regulations are expected to restrain the market growth over the forecast period. Get a Sample PDF copy of the Report: Get a Sample PDF copy of the Report: - - https://www.marketstatsville.com/request-sample/drug-discovery-market . © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

6. Global Drug Discovery Market Global Drug Discovery Market Dynamics Dynamics Drivers: Rising prevalence of various chronic Drivers: Rising prevalence of various chronic diseases diseases The increasing incidence of chronic diseases such as cardiovascular disease, diabetes, cancers, gastrointestinal tract infections, and other diseases is the major factor for the drug discovery market's growth. According to the research article published in Preventing Chronic Disease, 2020, the prevalence of chronic diseases in adults of the United States accounted for 27.2% in 2018. In contrast, it was 25.5% in 2012, 26.0% in 2010, and 21.8% in 2001. According to Globocan 2020, the new cancer cases that were diagnosed accounted for 19,292,789 in 2020 globally, with 9,958,133 deaths due to cancers globally. Among all cancers, breast cancer accounted to 2,261, 419 new cancer cases, followed by lung (2,206,771), Prostate (1,414,259) and colon (1,148,515) new cases in 2020. Additionally, as per the International Diabetes Federation Diabetes Altas Ninth Edition 2019, nearly 463 million globally live with diabetes worldwide and is expected to reach 700 million by 2045. The total health expenditure caused by diabetes was estimated to be USD 760 million in 2019 globally. The increasing incidence of diabetes and cancers raises the demand for targeted therapeutics to manage the diseases effectively. This aspect is expected to boost the growth of the studied market over the forecast period. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

7. Corresponding to the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics 2018, approximately 14.8 million adults were detected with ulcers. Nearly 22.4 million visits to physician offices were made with the digestive system's diseases as a primary diagnosis. Also, as per the Chronic Kidney Disease (CKD) Surveillance System, the prevalence of CKD was estimated to be 14.4% in 2020 and is expected to reach 16.7% by 2030. Hence, due to the surge in disease and awareness among patients for personalized treatment, there is a high need for newer, safe, and effective molecules, leading to drug discoveries. Restraints: Huge capital investment with low Restraints: Huge capital investment with low- -profit profit margins margins The cost for developing a drug depends on multiple factors, which ultimately results in a high monetary burden on the companies involved in drug discovery and development. According to a research article published in JAMA in 2020, the estimated median capitalized research and development cost per drug development was USD 985 million in 2018, including the expenditures on failed trials and the mean cost of developing a new drug had been estimated to range from USD 314 million to USD 2.8 billion. Some of the major factors for high cost include the cost of drug candidates' failures in trial stages. A high percentage of drugs tested on patients do not reach the market, unsafe or ineffective. Apart from that, the return on investment (ROI) is declining significantly, which keeps the pharmaceutical companies under pressure to increase their success rate in limited resources to reduce the cost of failure. Thus, the high capital investment into drug development with low-profit margins remains a major barrier in the drug discovery market. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

8. Opportunities: Increasing research and development investments for the development of novel Opportunities: Increasing research and development investments for the development of novel drug drug molecules molecules The research and development (R&D) expenditure by pharmaceutical companies has increased in the past few years. For instance, Pfizer spent USD 8,650 million in 2019, compared to USD 7,690 million on R&D in 2015. It directly translates to increased expenditure on drug discovery. As per a 2020 report by Olivier J. Wouters et al., published in the American Medical Association (JAMA) Journal, the estimated median capitalized research and development cost per product between 2009 and 2018 was USD 985 million, which also included expenditure on failed trials. As per the research article published in BioPharma Trend 2020, the rapid progress in artificial intelligence in the pharmaceutical industry for drug discovery is witnessed. This aspect is expected to boost the high investment in R&D activities of discovering new drug targets. Additionally, biotech investors are increasingly optimistic about the use of artificial intelligence in the field of drug discovery. They thus have been pouring heavy money into AI-based drug discovery approaches. For instance, in 2019, Xtalpi, an American Chinese-based biotech company, raised USD 319 million in funding to advance its Intelligent Digital Drug Discovery and Development (ID4) platform, which predicts small molecules candidates properties, solid-form selection, and other services. These research advances have resulted in many breakthrough innovations of highly effective drugs against various chronic diseases, which has led most investors to invest in drug discovery research and development. It has helped the market growth. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

9. Scope of the Scope of the Report Report The study categorizes the drug discovery market based on drug type, technology, and end user. By Drug By Drug Type Type Small Molecule Drugs Biologic Drugs By By Technology Technology High Throughput Screening Pharmacogenomics Combinatorial Chemistry Nanotechnology Other Technologies By End By End User User Pharmaceutical Companies Contract Research Organizations (CROs) Other End Users © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

10. By By Region Region North America (US, Canada, Mexico) South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America) Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe) Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific) The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA) Buy an exclusive copy: Buy an exclusive copy: - - https://www.marketstatsville.com/buy-now/drug-discovery-market?opt=2950 The small molecule drugs segment of the drug discovery market is projected to account for the largest share by mode of The small molecule drugs segment of the drug discovery market is projected to account for the largest share by mode of operation operation Based on the drug type, the drug discovery market has been segmented into small-molecule drugs and biologic drugs. In 2020, the small molecule drugs segment accounted for the largest share of 74%, with a market size of USD 40,672.4 million in the global drug discovery market. Small molecule drugs are thus found to play an important role in fighting diseases. Small molecules continue to maintain increasing applications in drug discovery and the development of biopharmaceutical companies. The small molecule drug discovery market is thus expected to witness huge growth owing to increasing small molecule drugs approval, rising demand for R&D from contract organizations, and rising adoption of small molecules in chronic disease treatments. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

11. In addition, the emergence of the COVID-19 pandemic is further accelerating this trend. Hence, the small-molecule drugs are heavily involved in developing therapies designated by the US Food and Drug Administration (FDA) as breakthrough therapies. All these factors have thus helped in driving the market growth. Asia Pacific accounts for the highest CAGR during the forecast period in the drug discovery market Asia Pacific accounts for the highest CAGR during the forecast period in the drug discovery market. . Based on the regions, the global drug discovery market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2020, North America accounted for the largest market share of 42.6%, which equals USD 23,378.72 million in 2020 and is further estimated to grow at a CAGR of 7.74% during the forecast period. Moreover, Asia Pacific is expected to grow at the highest CAGR of 10.25% from 2021 to 2027. The rising burden of cancer in China is also expected to drive the market. According to the Globocan 2020 data, there were 4.57 million cancer cases in 2020, and the number is projected to reach 5.81 million by the year 2030. Also, China has the highest number of people with diabetes, and nearly one in three adult diabetic patients is from China. According to the International Diabetes Federation (IDF), the prevalence of diabetes in adults in China in 2020 has been recorded at 10.9%, about 116,446,900 diabetes cases. The number of diabetes cases in China is expected to increase in the future, thus increasing the demand for pharmaceuticals. Therefore, the above-mentioned factors help the market to grow in the forecast period. Impact of COVID Impact of COVID- -19 on the Drug Discovery 19 on the Drug Discovery Market Market Most biotechnological and pharmaceutical companies are focusing their R&D departments on identifying new molecules or leads for the coronavirus disease treatments, which is in the final phase of clinical trials. Many countries, such as the UK and USA, have already approved Comirnaty (BNT162b2), an mRNA-based vaccine developed by Pfizer–BioNTech on December 3, 2020. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

12. Healthcare facilities such as diagnostic centers and hospitals have invested heavily in maintaining essential equipment and drugs. The medical equipment and pharmaceutical companies are also focusing on their R&D and manufacturing facilities to develop and manufacture essential medical devices and drugs. Amid the COVID-19 pandemic, countries' health systems are rapidly investing in research and development to combat the virus. Potential compounds were screened from the CHEMBL database, ZINC database, FDA-approved drugs, and molecules under clinical trials. Request for Report TOC, Table of Figure, Chart, Request for Report TOC, Table of Figure, Chart, etc market etc: :- -https://www.marketstatsville.com/table-of-content/drug-discovery- Key Market Key Market Players Players The major players of the studied market are Pfizer Inc., GlaxoSmithKline PLC, Merck & Co. Inc., Agilent Technologies Inc., and Eli Lilly and Company. These players have been adopting various winning strategies to gain higher shares or retain leading positions in the market. The key market players considering in the report scope are – Pfizer Inc. GlaxoSmithKline PLC Merck & Co. Inc. Agilent Technologies Inc. Eli Lilly and Company © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

13. F. Hoffmann-La Roche Ltd Bayer AG Abbott Laboratories Inc. Thermo Fisher Scientific Inc. Shimadzu Corp Additionally, the key players' increasing research and development activities to launch innovative drugs with advanced features and strategic alliances are expected to drive the market growth. For instance, on March 31, 2020, Existencia, an AI- based drug discovery company, entered a collaborative agreement with Diamond Light Source and Scripps Research for identifying COVID-19 antiviral therapies. It is anticipated to contribute to the growth of the market over the forecast period. Recent Recent Developments Developments In August 2020, Shimadzu Corporation and HORIBA Ltd an agreement to commence the collaboration on the development and sales of LC-Raman analytical and measuring instruments that combine Shimadzu’s high-performance liquid chromatographs (HPLCs, hereinafter LCs) with HORIBA’s Raman spectrometers. In January 2021, Thermo Fisher Scientific Inc. announced that it would be acquiring Mesa Biotech Inc., a privately held molecular diagnostic company. The deal was valued at approximately USD 450 million in cash. In June 2020, Abbott and Tandem Diabetes Care signed a partnership agreement to develop and commercialize integrated diabetes solutions. In October 2020, Bayer AG acquired Asklepios Biopharmaceutical Inc., a US-headquartered biopharmaceutical company specializing in researching, developing, and manufacturing gene therapies across different therapeutic areas. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

14. Key Issues Key Issues Addressed Addressed What is the market size by various segmentation of the drug discovery by region and its respective countries? What are the customer buying behavior, key takeaways, and Porter's 5 forces of the drug discovery market? What are the key opportunities and trends for manufacturers involved in the drug discovery supply chain? What are the fundamental dynamics (drivers, restraints, opportunities, and challenges) of the market? What and how regulations, schemes, patents, and policies are impacting the growth of the market? What are the upcoming technological solutions influencing market trends? How will existing companies adapt to the new change in technology? The market player positioning, top winning strategies by years, company product developments, and launches will be? How has COVID-19 impacted the demand and sales of Drug Discovery in the global market? Also, the expected BPS drop or rise count of the market and market predicted recovery period. Detailed analysis of the competitors and their latest launch, and what are the prominent startups introduced in the target market? Also, detailed company profiling of 25+ leading and prominent companies in the market. Request For Report Analysis: Request For Report Analysis: - - https://www.marketstatsville.com/drug-discovery-market © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

15. Research Methodology Market Statsville Group (MSG) research is conducted by industry experts who offer insight into industry structure, market segmentation, product assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years by analyzing historical trends and current market positions. Furthermore, the varying trends of the segments and categories are geographically presented, studied, and estimated based on primary and secondary research. Primary Primary Research Research – – Extensive primary research was conducted to gain a deeper insight into the market and industry performance. In this particular report we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, marketing directors, and business development managers) of the major players who are active in the global software testing market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next six years. Secondary Secondary Research technical, market-oriented, and commercial study of the global software testing market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization, some paid databases, and many others. Research – –Secondary research was mainly used to collect and identify information useful for the extensive, © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

16. Thank You Thank You Market Market Statsville Statsville Group (MSG) Group (MSG) F-178 Subhash Marg C Scheme, Ashok Nagar, Jaipur, Rajasthan, 302001 Phone : +91 702 496 8807 Mail : sales@marketstatsville.com 416, East Standsberry Street, Perkins, Oklahoma 74059, US Phone : +1 580 250 2707 Mail : sales@marketstatsville.com